Tinnitus: Clinical Trials

5 trials for Tinnitus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5

Follow Tinnitus: new trials by email Literature Review of Tinnitus trials Research Report on Tinnitus

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus
Drusen Mega®, Sertraline, Placebo - Tinnitus, Subjective, Tinnitus, Bilateral
Phase 2UnknownUniversity of Guadalajara582022-12-012023-04-07
Impact of Neurostimulation on Patterns of Brain Electrical Activity in Patients With Tinnitus
Transcranial Direct Current Stimulation, Sham Transcranial Direct Current Stimulation - Tinnitus
Phase 2UnknownFederal University of Paraíba542017-02-012017-01-30
Latanoprost for the Treatment of Menière's Disease
Latanoprost, Placebo - Menière's Disease
Phase 2UnknownSynphora AB1002013-10-012016-03-23
Transcranial Direct Current Stimulation (tDCS) for the Treatment of Tinnitus
BrainSTIM Transcranial Stimulator - Tinnitus
Phase 2UnknownCentre Hospitalier Universitaire Vaudois402012-04-012012-08-03
Effect of Gabapentin on Idiopathic Subjective Tinnitus
Gabapentin, placebo - Subjective Tinnitus
Phase 2UnknownIslamic Azad University of Mashhad702007-01-012009-01-06

Narrower conditions

Hearing Loss (1)  ·  Vertigo (1)

Broader conditions

Ear Diseases (5)  ·  Hearing Disorders (5)  ·  Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Otorhinolaryngologic Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Sensation Disorders (5)  ·  Signs and Symptoms (5)  ·  Labyrinth Diseases (1)  ·  Vestibular Diseases (1)

Interventions

Transcranial Direct Current Stimulation (2)  ·  Gabapentin (1)  ·  Geritol (1)  ·  Latanoprost (1)  ·  Magnesium Oxide (1)  ·  Sertraline (1)

Sponsors

Centre Hospitalier Universitaire Vaudois (1)  ·  Federal University of Paraíba (1)  ·  Islamic Azad University of Mashhad (1)  ·  Synphora AB (1)  ·  University of Guadalajara (1)

Countries

Brazil (1)  ·  Iran (1)  ·  Mexico (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

David Benninger, MD (1)  ·  Mahboobeh Adami Dehkordi, MD (1)  ·  Mikael Karlberg, MD, PhD (1)

Results publications

PMID 17960408, PMID 23827090